N-(4-pyridyl)-4-(1-aminoethyl)cyclohexanecarboxamide,
Y 27632,
Y 27632, (4(R)-trans)-isomer,
Y 27632, (4(S)-trans)-isomer,
Y 27632, (trans)-isomer,
Y 27632, dihydrochloride, (4(R)-trans)-isomer,
Y-27632,
Y27632,
y-27632,
146986-50-7,
Y-27632 dihydrochloride,
Y27632,
UNII-0X370ROP6H,
Y 27632,
cyclohexanecarboxamide, 4-[(1R)-1-aminoethyl]-N-4-pyridinyl-, trans-,
0X370ROP6H,
CHEBI:75393,
4-[(1R)-1-aminoethyl]-N-(pyridin-4-yl)cyclohexane-1-carboxamide,
(R)-TRANS-4-(1-AMINOETHYL)-N-(4-PYRIDYL) CYCLOHEXANECARBOXAMIDE,
4-[(1R)-1-aminoethyl]-N-(4-pyridyl)cyclohexanecarboxamide,
4-[(1R)-1-aminoethyl]-N-pyridin-4-ylcyclohexane-1-carboxamide,
(R)-(+)-trans-N-(4-pyridyl)-4-(1-aminoethyl)-cyclohexanecarboxamide,
(1R,4r)-4-[(1R)-1-aminoethyl]-N-(pyridin-4-yl)cyclohexane-1-carboxamide,
Y27,
(R)-Trans-4-(1-Aminoethyl)-N-(4-Pyridyl)cyclohexanecarboxamide,
2etr,
2gnf,
2gnj,
1q8t,
(R)-(+)-trans-4-(1-Aminoethyl)-N-(4-Pyridyl)cyclohexanecarboxamide dihydrochloride,
BiomolKI_000071,
BiomolKI2_000075,
Y-27632, free base,
AC1L9LJ8,
CBiol_001962,
BSPBio_001234,
KBioGR_000574,
KBioSS_000574,
SCHEMBL598993,
CHEMBL559147,
GTPL5290,
ROCK Inhibitor, Y-27632,
SCHEMBL1980406,
SCHEMBL7804373,
ZINC6989,
CHEMBL1083134,
CHEMBL1188380,
DTXSID7043740,
SCHEMBL13970844,
SCHEMBL18935698,
BDBM14029,
BDBM86729,
CHEBI:92773,
KBio2_000574,
KBio2_003142,
KBio2_005710,
KBio3_001027,
KBio3_001028,
BCPP000008,
Bio1_000248,
Bio1_000737,
Bio1_001226,
Bio2_000457,
Bio2_000937,
HMS1362N15,
HMS1792N15,
HMS1990N15,
HMS3403N15,
BDBM50319631,
AKOS026750241,
AKOS028109253,
AKOS030632781,
ZINC100002002,
ZINC252286763,
AM81233,
AN-5335,
CCG-204428,
CS-0131,
DB08756,
RL01853,
SB19471,
IDI1_002212,
SMP2_000199,
NCGC00092276-02,
NCGC00092276-03,
NCGC00092276-04,
NCGC00092276-05,
NCGC00092276-06,
NCGC00092276-07,
NCGC00092276-08,
NCGC00092276-09,
NCGC00092276-10,
HY-10071,
LS-191400,
CAS_146986-50-7,
FT-0601668,
A25646,
S-7699,
J-008296,
J-525164,
BRD-K44084986-001-03-9,
BRD-K44084986-300-02-7,
(R)-4-(1-aminoethyl)-N-(pyridin-4-yl)cyclohexane-1-carboxamide,
trans-4-[(1R)-1-aminoethyl]-N-(pyridin-4-yl)cyclohexanecarboxamide,
trans-4-[(1R)-1-aminoethyl]-N-pyridin-4-ylcyclohexanecarboxamide,
(1R)-4-[(1R)-1-aminoethyl]-N-(pyridin-4-yl)cyclohexane-1-carboxamide,
(R)-(+)-trans-4-(1-Aminoethyl)-N-(4-Pyridyl)cyclohexanecarboxamide,
[+]-[R]-trans-4-[1-aminoethyl]-N-[4-pyridyl]cyclohexanecarboxamide,
Cyclohexanecarboxamide, 4-(1-aminoethyl)-N-4-pyridinyl-, [4(R)-trans]-,
Cyclohexanecarboxamide, 4-[(1R)-1-aminoethyl]-N-4-pyridinyl-, trans- (9CI),
trans-4-[(1R)-1-Aminoethyl]-N-4-pyridinylcyclohexanecar boxamide dihydrochloride,
Ximelegatran,
D0B5LF,
D0W5QE,
Y 27632, (trans)-isomer,
IYOZTVGMEWJPKR-VOMCLLRMSA-N,
CID448042,
Y 27632, (4(R)-trans)-isomer,
Y 27632, (4(S)-trans)-isomer,
ACN-038215,
A3008,
B1293,
C108830,
Y 27632, dihydrochloride, (4(R)-trans)-isomer,
N-(4-pyridyl)-4-(1-aminoethyl)cyclohexanecarboxamide,
Cyclohexanecarboxamide,4-[ -1-aminoethyl]-N-4-pyridinyl-,
(1R,4r)-4-((R)-1-aminoethyl)-N-(pyridin-4-yl)cyclohexanecarboxamide dihydrochloride,
(1R,4r)-4-((R)-1-aminoethyl)-N-(pyridin-4-yl)cyclohexanecarboxamide,
521059-79-0,
Cyclohexanecarboxamide, 4-[(1R)-1-aminoethyl]-N-4-pyridinyl- (9CI),
(1R,4r)-4-((R)-1-aminoethyl)-N-(pyridin-4-yl)cyclohexane-1-carboxamide dihydrochloride,
138381-45-0,
172889-27-9,
192939-46-1,
pp2,